info@seagull-health.com
SeagullHealth
语言:
search
new
Dosage and Administration of Amlodipine - Recommended Doses
500
Article source: Seagull Pharmacy
Dec 17, 2025

Amlodipine is a long-acting dihydropyridine calcium channel blocker, widely used in the treatment of hypertension and angina pectoris.

Dosage and Administration of Amlodipine - Recommended Doses

Dosage for Hypertension Treatment

The usual initial oral dose for adult patients with hypertension is 5 mg once daily.

A starting dose of 2.5 mg may also be used when amlodipine orally disintegrating tablets are added to other antihypertensive treatment regimens.

Dosage for Angina Pectoris Treatment

The recommended dose for chronic stable angina or vasospastic angina is 5 to 10 mg once daily.

A lower dose is recommended for elderly patients and patients with hepatic insufficiency.

Most patients require a dose of 10 mg to achieve adequate therapeutic effect.

Dosage for Pediatric Patients

The effective antihypertensive oral dose for pediatric patients aged 6 to 17 years with hypertension is 2.5 mg to 5 mg once daily.

The safety of daily doses exceeding 5 mg has not been studied in pediatric patients.

Administration Instructions

Amlodipine orally disintegrating tablets have a special administration method: place the tablet on the tongue, allow it to disintegrate, and then swallow it with saliva; water may be taken to facilitate swallowing if necessary.

This administration method improves medication convenience, making it particularly suitable for patients with dysphagia.

Dosage Adjustment of Amlodipine

Adjustment Based on Therapeutic Efficacy

Dosage adjustment should be individualized according to the specific needs of each patient.

The magnitude of blood pressure reduction with amlodipine is correlated with the degree of baseline blood pressure elevation.

Patients with moderate hypertension have a response approximately 50% greater than that of patients with mild hypertension.

Adjustment for Combination Therapy

When used in combination with other antihypertensive drugs, consideration should be given to initiating treatment at a lower dose.

Close monitoring of blood pressure changes is required, especially when combined with diuretics, angiotensin-converting enzyme inhibitors, beta-blockers and other medications.

Usage in Special Populations of Amlodipine

Patients with Hepatic Insufficiency

Elderly patients and patients with hepatic insufficiency have reduced clearance of amlodipine, resulting in an approximately 40% to 60% increase in area under the concentration-time curve (AUC).

Therefore, a lower initial dose may be required.

Usage in Elderly Patients

Elderly individuals have reduced clearance of amlodipine, leading to a 40% to 60% increase in AUC.

It is generally recommended to initiate treatment at the lower end of the dosage range.

Pregnant and Lactating Women

During pregnancy, amlodipine should be used only if the potential benefit justifies the potential risk to the fetus.

Lactating women should discontinue breastfeeding or choose an alternative medication, as it is unknown whether amlodipine is excreted in human milk.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What are the Indications for Amlodipine?
Amlodipine is a long-acting calcium channel blocker that plays an important role in the treatment of cardiovascular diseases. Its orally disintegrating tablet (ODT) formulation further enhances the co...
Where to Purchase Amlodipine
Amlodipine is a long-acting calcium channel blocker widely used in the treatment of hypertension, chronic stable angina pectoris, and vasospastic angina pectoris. As a prescription drug, its standardi...
Adverse Reactions of Pemigatinib (Pemazyre)
Pemigatinib (Pemazyre) is a targeted therapy indicated for the treatment of specific types of cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FGFR1 rearrangement.Adverse Reactions of Pemi...
What are the Precautions for Taking Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an important targeted therapy for specific gene mutations, playing a pivotal role in the treatment of advanced cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FG...
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the l...
What are the Indications for Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a novel fixed-dose combination antihyperglycemic medication. It integrates two hypoglycemic ingredients with distinct mechanisms of actio...
Dosage and Administration, Recommended Dosage of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a fixed-dose combination oral antihyperglycemic medication. It combines sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, with met...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved